TABLE 1.
Parameter | Mean Parameter Estimate | S.E | P Value |
---|---|---|---|
F_pop | 0.175 | 0.0072 | |
θ_Pgp KO | 0.227 | 0.062 | 0.00028 |
θ_dKO | 0.514 | 0.062 | <1e−10 |
Tk0_pop (1/h) | 0.104 | 0.0092 | |
F2_pop | 1 fixed | N.E. | |
ka_pop (1/h) | 19.1 | 1.6 | |
V1_pop (1/kg) | 9.32 | 0.35 | |
CL_pop (1/h per kilogram) | 20.2 | 0.72 | |
ω_BSV | |||
F | 0.0276 | 0.077 | |
Tk0 | 0.32 | 0.077 | |
F2 | N.E. | N.E. | |
ka | 0.091 | 0.14 | |
V1 | 0.0857 | 0.061 | |
CL | 0.0781 | 0.056 | |
σ-RUV | |||
Proportional | 0.341 | 0.022 | |
F_(WT and Bcrp KO) | 0.175 | 0.0072 | |
F_(Pgp KO) | 0.22 | 0.011 | |
F_(dKO) | 0.293 | 0.015 |
CL_pop, population mean clearance; F, oral bioavailability; F_pop, population mean oral bioavailability; F2_pop, population mean intraperitoneal bioavailability (which was assumed to be 1); ka_pop, population mean first-order absorption rate constant for the intraperitoneal route; N.E. : Not Estimated., ; ω_BSV, between-subject variability; σ-RUV, residual unexplained variability; θ_Pgp KO and θ_dKO, estimated coefficient of the effect of categorical covariate Pgp KO and dKO on the oral bioavailability; Tk0_pop, population mean oral zero-order absorption rate constant; V1_pop, population mean volume of distribution.